Home » Reports » Broker Ratings » AstraZeneca plc 8.7% Potential Upside Indicated by Credit Suisse

AstraZeneca plc 8.7% Potential Upside Indicated by Credit Suisse

AstraZeneca plc using EPIC/TICKER code (LON:AZN) has had its stock rating noted as ‘Reiterates’ with the recommendation being set at ‘OUTPERFORM’ this morning by analysts at Credit Suisse. AstraZeneca plc are listed in the Health Care sector within UK Main Market. Credit Suisse have set their target price at 8500 GBX on its stock. This would indicate that the analyst believes there is a potential upside of 8.7% from the opening price of 7823 GBX. Over the last 30 and 90 trading days the company share price has increased 373 points and increased 1002 points respectively. The 1 year high share price is 7838.77 GBX while the 52 week low for the stock is 5312 GBX.

AstraZeneca plc has a 50 day moving average of 8,910.14 GBX and a 200 Day Moving Average share price is recorded at 7,258.34. There are currently 28,085,530 shares in issue with the average daily volume traded being 2,111,620. Market capitalisation for LON:AZN is £101,703,814,519 GBP.